Skip to main navigation Skip to search Skip to main content

Evaluation of dual-lumen pulmonary artery cannulation in extracorporeal right ventricular support

  • Valeria Lo Coco
  • , Michele Di Mauro
  • , Silvia Mariani
  • , Elham Bidar
  • , Kasia Hryniewicz
  • , Antonio Loforte
  • , Thomas Fux
  • , Sam Heuts
  • , Dominik Wiedemann
  • , Michal Kawcynsky
  • , Tom Verbelen
  • , Lars Mikael Broman
  • , Jamila Kremer
  • , Matteo Pozzi
  • , Koji Takeda
  • , Udo Boeken
  • , Yih-Sharng Chen
  • , Paolo Masiello
  • , Dominik J. Vogel
  • , Jacinta J. Maas*
  • Andrea Ballotta, Federico Pappalardo, Sandro Gelsomino, Roberto Lorusso*, PLACE Investigators
*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Objective: To evaluate whether dual-lumen (DL) versus single-lumen (SL) pulmonary artery cannulation improves outcomes in patients with refractory right ventricular failure (RVF) supported with extracorporeal life support and to identify which patients benefit most. Methods: We conducted a multicenter retrospective cohort study using the international PLACE registry (2000-2020). Adults undergoing pulmonary artery cannulation for isolated RVF were included. Outcomes were in-hospital and 30-day mortality, bleeding, thromboembolic events, continuous renal-replacement therapy, and length of stay. Propensity score weighting was applied to adjust for baseline differences. Prespecified analyses tested effect modification by hypoxemia, renal function, platelet count, cannulation site, and oxygenator use. Mediation and clustering were used to explore physiological pathways and phenotypes. Results: Among 345 patients, DL cannulation was associated with lower postoperative lactate and creatinine and with fewer bleeding events. In weighted multivariable models, DL reduced the risk of bleeding and the composite of bleeding or thromboembolism (weighted odds ratio, 0.50; 95% CI 0.32-0.77; P = .0017 and weighted odds ratio, 0.57; 95% CI 0.39-0.84; P = .004). Hypoxemia significantly strengthened the survival benefit of DL, whereas cannulation site and oxygenator use did not modify outcomes. Mediation analyses indicated that the effect of DL on survival was indirect, operating through early improvement in perfusion and renal function. Unsupervised clustering identified distinct postoperative biochemical phenotypes with markedly different prognoses; DL was associated with a shift toward favorable profiles. Conclusions: In extracorporeal life support for RVF, DL pulmonary artery cannulation improves outcomes primarily by enhancing early organ function and reducing complications. Patients with baseline hypoxemia appear to benefit most, supporting a physiology-guided approach to cannulation strategy.
Original languageEnglish
Article number101699
Number of pages10
JournalJTCVS open
Volume30
DOIs
Publication statusPublished - 1 Apr 2026

Keywords

  • Key Words
  • dual-lumen cannulation
  • right ventricular failure
  • venovenous ECMO
  • hypoxemia
  • causal mediation
  • MEMBRANE-OXYGENATION
  • EPIDEMIOLOGY
  • STATEMENT
  • FAILURE

Fingerprint

Dive into the research topics of 'Evaluation of dual-lumen pulmonary artery cannulation in extracorporeal right ventricular support'. Together they form a unique fingerprint.

Cite this